Management of metastatic melanoma 2005

Surgical Oncology Clinics of North America
Steven O'Day, Peter Boasberg

Abstract

The management of metastatic melanoma in 2005 remains a major clinical challenge. Multidisciplinary treatment planning and careful attention to sites of metastases, tumor biology, and comorbid conditions are critical to making the best clinical decisions for individual patients. No standard of care exists because no systemic therapies have yet shown efficacy in phase III trials. Single-agent or combination chemotherapy has not impacted over-all survival, and response rates are of short duration. High-dose IL-2 produces durable responses in a small subset (7%) of highly selected patients and has considerable toxicity and quality-of-life trade-offs. Biochemotherapy results in overall higher responses, but its impact on overall survival has been disappointing and its toxicity and expense are considerable. Re-searchers are further investigating biochemotherapy modifications with maintenance biotherapy and CNS consolidation in effort to increase durability of responses and prevent or delay the devastating sequela of CNS metastases. Despite a disappointing past, the advancement of science and a better understanding of critical cellular targets and pathways make the future of melanoma research encouraging. Clinical trials are actively...Continue Reading

References

Feb 11, 1975·Cancer·J J CostanziF C Delaney
Nov 1, 1992·Seminars in Surgical Oncology·C M Balch
Aug 20, 1992·The New England Journal of Medicine·G CocconiP Costa
Feb 1, 1991·Investigational New Drugs·A I EinzigT J Smith
May 1, 1991·Cancer Metastasis Reviews·R H KramerD M Ramos
Jun 1, 1990·Cancer·S S LeghaR S Benjamin
Nov 15, 1990·Cancer·K BregaW Wittenberg
Aug 1, 1986·Annals of Surgery·I L WornomC M Balch
Aug 1, 1987·Archives of Dermatology·J C BystrynA Kopf
Jan 1, 1971·Journal of Surgical Oncology·W L JosephP C Adkins
Nov 1, 1983·Journal of the American Academy of Dermatology·J J NordlundA B Lerner
Dec 2, 1993·International Journal of Cancer. Journal International Du Cancer·E F McClayS B Howell
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D KhayatG Auclerc
Sep 1, 1996·Archives of Surgery·D W OllilaD L Morton
Oct 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S S LeghaN Papadopoulos
Aug 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P N MainwaringM E Gore
Jan 12, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D BafaloukosP Kosmidis
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Omar EtonRobert S Benjamin
Jun 1, 2002·American Journal of Clinical Oncology·F Stephen HodiFrank G Haluska
Feb 13, 2004·International Journal of Cancer. Journal International Du Cancer·Julia ReifenbergerGuido Reifenberger
Mar 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John M KirkwoodUNKNOWN Eastern Cooperative Oncology Group
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M F AvrilY Menu
Apr 20, 2004·International Journal of Cancer. Journal International Du Cancer·Mohit TrikhaMarian T Nakada

❮ Previous
Next ❯

Citations

Nov 17, 2007·The Journal of Clinical Investigation·Kimberly B PetermannNorman E Sharpless
Mar 18, 2008·Cancer Immunology, Immunotherapy : CII·Oliver G GoldsteinAzizul Haque
Sep 25, 2007·Surgical Oncology·Pamela M Aubert, Richard J O'Donnell
Jun 27, 2007·Clinical Techniques in Small Animal Practice·Philip J Bergman
Aug 23, 2011·Journal of Surgical Oncology·David W OllilaEddy C Hsueh
Mar 15, 2015·Surgical Oncology Clinics of North America·Gary B DeutschMark B Faries
Sep 29, 2011·Clinical Journal of Oncology Nursing·Ruth-Ann Roman
Oct 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven O'DayEric Jacobson
Apr 29, 2014·Anais Brasileiros De Dermatologia·Michele Ceolin Foletto, Sandra Elisa Haas
May 9, 2008·Journal of Immunotherapy·Ulrich Keilholz
Apr 3, 2008·Journal of Immunotoxicology·Rafael Ponce
May 2, 2014·Melanoma Research·Matthew W ColmanRichard L McGough
Dec 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ralph J Abi-HabibArthur E Frankel
Sep 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wanhua YangDing Ma
Feb 28, 2008·Current Opinion in Oncology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved